These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14100895)

  • 21. A CONTROLLED TRIAL OF ATROMID IN CEREBRAL VASCULAR DISEASE. A PRELIMINARY REPORT.
    ACHESON J; HUTCHINSON EC
    J Atheroscler Res; 1963; 3():711-5. PubMed ID: 14100916
    [No Abstract]   [Full Text] [Related]  

  • 22. STUDIES ON LOW-DENSITY LIPOPROTEIN TURNOVER IN RELATION TO ATROMID THERAPY.
    WALTON KW; SCOTT PJ; VERRIERJONES J; FLETCHER RF; WHITEHEAD T
    J Atheroscler Res; 1963; 3():396-414. PubMed ID: 14100881
    [No Abstract]   [Full Text] [Related]  

  • 23. SERUM LIPID AND LIPOPROTEIN CHANGES AFTER TREATMENT WITH ATROMID IN PATIENTS WITH ATHEROSCLEROSIS, ESSENTIAL HYPERLIPAEMIA AND FAMILIAL HYPERCHOLESTEROLAEMIA.
    FASOLI A; CESANA A
    J Atheroscler Res; 1963; 3():475-81. PubMed ID: 14100888
    [No Abstract]   [Full Text] [Related]  

  • 24. THE TREATMENT OF XANTHOMATOSIS WITH "ATROMID".
    MISHKEL MA
    Med J Aust; 1964 Nov; 2():828-33. PubMed ID: 14226559
    [No Abstract]   [Full Text] [Related]  

  • 25. THE EFFECTS OF ATROMID ON THE ALPHA-BETA-LIPOPROTEIN RATIO IN CORONARY DISEASE.
    KERNOHAN RJ; NEELY RA
    J Atheroscler Res; 1963; 3():518-24. PubMed ID: 14100892
    [No Abstract]   [Full Text] [Related]  

  • 26. BETA-LIPOPROTEIN, LIPOPROTEIN LIPASE AND ATROMID.
    HOOD B; BEDDING P; CARLANDER B
    J Atheroscler Res; 1963; 3():509-17. PubMed ID: 14100891
    [No Abstract]   [Full Text] [Related]  

  • 27. CHANGES IN SERUM LIPIDS WITH ATROMID AND CHLOROPHENOXYISOBUTYRIC ESTER.
    ROBINSON RW
    J Atheroscler Res; 1963; 3():566-70. PubMed ID: 14100900
    [No Abstract]   [Full Text] [Related]  

  • 28. A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
    PEAK HJ; MITCHELL AS; JOSE AD
    Med J Aust; 1965 Jul; 2(5):192-4. PubMed ID: 14348329
    [No Abstract]   [Full Text] [Related]  

  • 29. ATROMID IN THE TREATMENT OF POST-CLIMACTERIC DIABETES.
    MILLER RD
    J Atheroscler Res; 1963; 3():694-700. PubMed ID: 14100914
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements.
    OLIVER MF; ROBERTS SD; HAYES D; PANTRIDGE JF; SUZMAN MM; BERSOHN I
    Lancet; 1963 Jan; 1(7273):143-4. PubMed ID: 13940003
    [No Abstract]   [Full Text] [Related]  

  • 31. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    HOWARD RP; ALAUPOVIC P; BRUSCO OJ; FURMAN RH
    J Atheroscler Res; 1963; 3():482-99. PubMed ID: 14100889
    [No Abstract]   [Full Text] [Related]  

  • 32. [CHOLESTEROL AND BLOOD LIPID BEHAVIOR IN ARTERIOSCLEROSIS UNDER THE EFFECTS OF PROTECTED ANDROSTERONE (ATROMID)].
    MARIN R; GARCIAFERNANDEZ JL; GARCIAOTERO V; RODRIGUEZPUCHOL J; PESCADOR L
    Rev Esp Cardiol; 1964 Jul; 17():563-73. PubMed ID: 14232044
    [No Abstract]   [Full Text] [Related]  

  • 33. "ATROMID" IN ATHEROSCLEROSIS.
    BARNETT AJ; CARSON V; DE MEIRING PV
    Med J Aust; 1964 Jul; 2():19-24. PubMed ID: 14175311
    [No Abstract]   [Full Text] [Related]  

  • 34. LABELED PLASMA LIPIDS AFTER INGESTION OF RADIOACTIVE FATS.
    SISSON JC
    J Nucl Med; 1965 Mar; 6():210-9. PubMed ID: 14288442
    [No Abstract]   [Full Text] [Related]  

  • 35. CLINICAL OBSERVATIONS ON PATIENTS TREATED WITH ATROMID AND ANTICOAGULANTS.
    ROGEN AS; CAMPBELLFERGUSON J
    J Atheroscler Res; 1963; 3():671-6. PubMed ID: 14100911
    [No Abstract]   [Full Text] [Related]  

  • 36. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.
    HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
    J Atheroscler Res; 1963; 3():454-66. PubMed ID: 14100886
    [No Abstract]   [Full Text] [Related]  

  • 37. THE EFFECT OF ATROMID ON PLASMA FIBRINOGEN AND HEPARIN RESISTANCE.
    COTTON RC; WADE EG; SPILLER GW
    J Atheroscler Res; 1963; 3():648-52. PubMed ID: 14100908
    [No Abstract]   [Full Text] [Related]  

  • 38. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 39. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.